Launch of ‘Favavir’. – Adarsh Maharashtra


Hetero, one of India’s leading generic pharmaceutical companies and the world’s largest producer of antiretroviral drugs, today announces the launch of ‘Favivir’ (Favipiravir 200 mg) in India to treat mild to moderate Covid-19. 

Related posts

Finance Minister clarifies EL not applicable on e-trade of rough diamonds* – Adarsh Maharashtra


Bengaluru startup ‘IDSign’ participates at India’s first-ever ‘Global Fintech Fest’ powered by IAMAI .An innovative digital format event to decipher the global financial service and fintech opportunities- -The event to witness participants from 50+ countries, 100+ speakers, 10,000+ delegates and 1,00,000+ viewership- – Adarsh Maharashtra


Hindware Italian Collection brings the future of bathroom to India – the luxurious ‘Tankless Wall-Mounted EWC’. – Adarsh Maharashtra


Leave a Comment